Bright Minds Biosciences DRUG Total Debt

DRUG Total Debt in 2022: $0

According to Bright Minds Biosciences latest financial reports the total debt is $0, an decrease of -100.00% to 2022. At the end of 2022 company had $52.87K total debt. This figure represents the debts and financial obligations that Bright Minds Biosciences combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.

Bright Minds Biosciences DRUG Total Debt History from 2023 to 2022

DRUG Total Debt by year

View the Top Total Debt Stocks